Subclinical Infection & Cytokines In Preterm Parturition

亚临床感染

基本信息

项目摘要

Premature birth is the leading cause of perinatal mortality and morbidity worldwide. The Perinatology Research Branch has defined preterm labor as a syndrome and determined that at least 25% of preterm births are born to women with sub-clinical intrauterine infection. Moreover, we have provided evidence that many premature neonates are critically ill before birth and proposed that the onset of premature labor has survival value in the context of intrauterine infection. The goal of this project is to understand the pathophysiology of premature labor and delivery and the focus of our research this year was to study the role of matrix degrading enzymes in preterm premature rupture of membranes. The focus of the Branch this year was understanding the role of the innate immune system in the mechanisms of preterm parturition. The findings that were noteworthy include: 1. Maternal serum of women with preeclampsia reduces trophoblast cell viability: evidence for an increased sensitivity to fas-mediated apoptosis: Preeclampsia, or "toxemia of pregnancy," has been attributed to the presence of a circulating "toxin" that disappears from peripheral blood after delivery of the placenta. However, the presence, nature and effects of this toxin have eluded characterization. Increased trophoblast apoptosis has been observed in the placenta of women with preeclampsia, and it is possible that this biological phenomenon is important for the genesis of the disease and mediated through a soluble factor(s) present in maternal blood. The Branch conducted a study to determine whether serum from women with preeclampsia changes trophoblast viability. H8 trophoblast cells were cultured with serum obtained from normal pregnant women and patients with preeclampsia. Cell viability was determined by Cell Titer 96 Assay. Fas sensitivity was determined by treating the cells with an anti-Fas antibody or a blocking anti-Fas Ligand antibody. Serum from normal pregnant women did not affect trophoblast cell viability. In contrast, serum from preeclamptic women reduced trophoblast viability, and this was enhanced by treatment with an anti-Fas antibody. This effect was reversed by the treatment with a blocking anti-Fas Ligand antibody. We conclude that serum from women with preeclampsia induces cytotoxicity of first trimester trophoblast cell line (H8). This effect appears to be related to changes in trophoblast sensitivity to Fas-mediated apoptosis. These findings suggest that a factor present in maternal blood of patients with preeclampsia may have a role in the genesis of the syndrome. Future studies will be aimed to determine whether this factor is present prior to the development of the disease. 2. Antimicrobial factors in the amniotic fluid of normal women and those with preterm labor and premature rupture of membranes: The amniotic cavity is considered a sterile compartment, presumably accomplished by the participation of the innate immune system, which includes the cervical epithelium, cervical mucus plug, chorioamniotic membranes, cellular components of decidua, amnion and chorion, including neutrophils, macrophages, NK cells and trophoblast. Although intact chorioamniotic membranes are thought to protect against microbial invasion of the cavity (MIAC), this physical barrier alone cannot be responsible for the sterile nature of amniotic fluid (AF) in normal pregnancy because bacteria can cross the intact membranes. Indeed, patients with intact membranes can have MIAC, as this has been demonstrated in patients in the midtrimester of pregnancy, with preterm labor and intact membranes or even spontaneous labor at term. This suggests that in addition to the physical barrier, other mechanisms must be operative to prevent bacterial proliferation within the amniotic cavity. Antimicrobial peptides, part of the innate limb of the immune response, have been identified in plants, insects and all vertebrates examined thus far. Neutrophils contain several antimicrobial peptides including neutrophil defensins [Human Neutrophil Peptides (HNP) 1, 2, and 3], Bactericidal/Permeability-Increasing Protein (BPI) and calprotectin (MRP8/14). The purpose of this study was to determine if AF contains immunoreactive antimicrobial peptides (HNP 1-3, BPI and MRP8/14) and whether their concentration changes with MIAC, parturition and premature rupture of membranes (PROM). The Branch conducted a series of studies that yielded the following: 1) Intraamniotic infection is associated with a significant increase in AF concentrations of HNP1-3, BPI and calprotectin in both women with preterm labor and intact membranes, and women with preterm PROM. 2) Preterm PROM is associated with a significant increase in AF concentrations of HNP 1-3, BPI and calprotectin. 3) Preterm parturition is associated with a significant increase in AF concentrations of HNP 1-3, BPI and calprotectin, while term parturition is associated with a significant increase in AF concentrations of immunoreactive HNP 1-3. 4) Among patients with preterm labor and intact membranes, elevation of AF HNP 1-3, BPI and calprotectin concentrations was associated with intraamniotic inflammation, histologic chorioamnionitis and short interval to delivery. 3. The effect of antibiotic therapy on intrauterine infection-induced preterm parturition in rabbits: Microbial invasion of amniotic fluid cavity and sub-clinical intrauterine infection have been implicated as one of the mechanisms responsible for preterm labor and delivery. Consequently, investigators have examined whether the administration of antibiotics to women in preterm labor with intact membranes and preterm premature rupture of membranes (PROM) can prolong pregnancy and improve neonatal outcome. There are conflicting results from different randomized clinical trials and meta-analysis. The Cochrane Review concluded that routine use of antibiotics is not effective in the prevention of preterm parturition with intact membranes. In contrast, animal experiments suggest that, in some instances, antibiotic administration can reduce intra-amniotic bacterial load and preterm delivery, as well as improve neonatal survival. One possible explanation for the ineffectiveness in humans is that antibiotics must be administered early to be effective and that when patients present with clinical preterm labor and intraamniotic infection, it is too late to down-regulate the inflammatory response and thus antimicrobial therapy cannot prevent preterm parturition and/or fetal damage. A rabbit model of ascending uterine infection was used to assess whether there is a time-dependent relationship between antibiotic administration and the prevention of preterm parturition. We conducted a study in which rabbits were inoculated with E. Coli without antibiotic treatment delivered prematurely. The median inoculation-to-delivery interval was significantly shorter in the infected group than in the control group [36.3 hours (15-76.5) vs. 219 hours (173-240), p<0.001]. Antibiotic administration within 12 hours, but not after 18 hours, of inoculation increased the duration of pregnancy (by reducing the rate of preterm delivery) and neonatal survival (0% vs. 71%; p<0.005). We found that antibiotic administration can prolong pregnancy and reduce perinatal mortality after an ascending intrauterine infection only if administered early (less than 12 hours) after microbial inoculation. Whether this approach could also reduce neonatal morbidity remains to be determined. The importance of this observation is the need for the rapid and early identification of intraamniotic infection in humans.

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROBERTO ROMERO其他文献

ROBERTO ROMERO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROBERTO ROMERO', 18)}}的其他基金

CANDIDATE GENE ANALYSIS OF ADVERSE OBSTETRICAL OUTCOMES
不良产科结局的候选基因分析
  • 批准号:
    7420626
  • 财政年份:
    2006
  • 资助金额:
    --
  • 项目类别:
CANDIDATE GENE ANALYSIS OF ADVERSE OBSTETRICAL OUTCOMES
不良产科结局的候选基因分析
  • 批准号:
    7181280
  • 财政年份:
    2005
  • 资助金额:
    --
  • 项目类别:
PRENATAL DIAGNOSIS OF CONGENITAL ANOMALIES
先天性异常的产前诊断
  • 批准号:
    6108124
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
The Role Of Subclinical Infection And Cytokines In Preterm Parturition
亚临床感染和细胞因子在早产中的作用
  • 批准号:
    8941476
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Prenatal Diagnosis Of Congenital Anomalies
先天性异常的产前诊断
  • 批准号:
    7208934
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Prenatal Diagnosis Of Congenital Anomalies
先天性异常的产前诊断
  • 批准号:
    6992996
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
The Role Of Subclinical Infection And Cytokines In Prete
亚临床感染和细胞因子在 Prete 中的作用
  • 批准号:
    7334071
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
PRENATAL DIAGNOSIS OF CONGENITAL ANOMALIES
先天性异常的产前诊断
  • 批准号:
    6432591
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
The Role Of Subclinical Infection And Cytokines In Preterm Parturition
亚临床感染和细胞因子在早产中的作用
  • 批准号:
    7968617
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
The Role Of Subclinical Infection And Cytokines In Preterm Parturition
亚临床感染和细胞因子在早产中的作用
  • 批准号:
    8351155
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似国自然基金

Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 批准年份:
    2020
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 批准年份:
    2017
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 批准年份:
    2016
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 批准年份:
    2014
  • 资助金额:
    73.0 万元
  • 项目类别:
    面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
  • 批准号:
    81301123
  • 批准年份:
    2013
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
  • 批准号:
    81101529
  • 批准年份:
    2011
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
  • 批准号:
    39500043
  • 批准年份:
    1995
  • 资助金额:
    9.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Early detection of radiation induced apoptosis by 99mTc-Annexin V andFDG in a lung cancer cell line.
99mTc-Annexin V 和 FDG 在肺癌细胞系中早期检测辐射诱导的细胞凋亡。
  • 批准号:
    22591357
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A study of cell survival mechanisms for apoptosis-resistant oral squamous cell carcinoma cell line
抗凋亡口腔鳞状细胞癌细胞系的细胞存活机制研究
  • 批准号:
    15592137
  • 财政年份:
    2003
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Involvement molecular chaperone in apoptosis signaling in human salivary gland cell line
分子伴侣参与人唾液腺细胞系凋亡信号传导
  • 批准号:
    14571772
  • 财政年份:
    2002
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Lactoferrin-induced apoptosis and PLD activation in oral squamous cell carcinoma cell line
乳铁蛋白诱导口腔鳞状细胞癌细胞系凋亡和 PLD 激活
  • 批准号:
    13672128
  • 财政年份:
    2001
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
INVESTIGATION OF MECHANISMS OF CDDP-INDUCED APOPTOSIS IN THE CDDP-RESISTANT A431 CELL LINE
CDDP抗性A431细胞系中CDDP诱导凋亡机制的研究
  • 批准号:
    10671880
  • 财政年份:
    1998
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Induction of Apoptosis to Rat Thyroid Follicular Epithelial Cell Line, FRTL-5 Cell
诱导大鼠甲状腺滤泡上皮细胞系 FRTL-5 细胞凋亡
  • 批准号:
    08670199
  • 财政年份:
    1996
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of the intracellular mechanisms of cisplatin-induced apoptosis in renal cell line
阐明顺铂诱导肾细胞系凋亡的细胞内机制
  • 批准号:
    08671297
  • 财政年份:
    1996
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
C-MYC EXPRESSION AND APOPTOSIS IN A B CELL LINE
B 细胞系中的 C-MYC 表达和凋亡
  • 批准号:
    2089092
  • 财政年份:
    1984
  • 资助金额:
    --
  • 项目类别:
C-MYC EXPRESSION AND APOPTOSIS IN A B CELL LINE
B 细胞系中的 C-MYC 表达和凋亡
  • 批准号:
    2089091
  • 财政年份:
    1984
  • 资助金额:
    --
  • 项目类别:
C-MYC EXPRESSION AND APOPTOSIS IN A B CELL LINE
B 细胞系中的 C-MYC 表达和凋亡
  • 批准号:
    6164108
  • 财政年份:
    1984
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了